Recent applications of regenerative medicine to urologic structures and related tissues

Anthony Atala

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Purpose of review: A severe shortage of donor tissues and organs exists, which is worsening yearly given the aging population. Currently, patients suffering from diseased and injured organs are treated with transplanted organs or cells. This paper reviews recent advances that have occurred in regenerative medicine and describes application of new technologies to treat diseased or damaged organs and tissues. Recent findings: Although most current strategies for tissue engineering depend upon a sample of autologous cells from the diseased organ of the patient, biopsies from patients with extensive end-stage organ failure may not yield enough normal cells. In these situations, stem cells are envisioned as being an alternative source. Stem cells can be derived from discarded human embryos (human embryonic stem cells), from fetal tissue, or from adult sources (bone marrow, fat, skin). Therapeutic cloning offers a potentially limitless source of cells for tissue engineering applications. Summary: Recently, scientists in the fields of regenerative medicine and tissue engineering have applied the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues.

Original languageEnglish
Pages (from-to)305-309
Number of pages5
JournalCurrent Opinion in Urology
Volume16
Issue number4
DOIs
StatePublished - Jul 1 2006
Externally publishedYes

Fingerprint

Regenerative Medicine
Tissue Engineering
Stem Cells
Tissue Donors
Cell Engineering
Bioengineering
Cell Transplantation
Organism Cloning
Fetus
Embryonic Structures
Bone Marrow
Fats
Technology
Biopsy
Skin
Population
Therapeutics

Keywords

  • Bladder
  • Genital
  • Kidney
  • Reconstruction
  • Regenerative medicine

ASJC Scopus subject areas

  • Urology

Cite this

Recent applications of regenerative medicine to urologic structures and related tissues. / Atala, Anthony.

In: Current Opinion in Urology, Vol. 16, No. 4, 01.07.2006, p. 305-309.

Research output: Contribution to journalArticle

@article{85489c2de52b4a6b97842afcff731fd5,
title = "Recent applications of regenerative medicine to urologic structures and related tissues",
abstract = "Purpose of review: A severe shortage of donor tissues and organs exists, which is worsening yearly given the aging population. Currently, patients suffering from diseased and injured organs are treated with transplanted organs or cells. This paper reviews recent advances that have occurred in regenerative medicine and describes application of new technologies to treat diseased or damaged organs and tissues. Recent findings: Although most current strategies for tissue engineering depend upon a sample of autologous cells from the diseased organ of the patient, biopsies from patients with extensive end-stage organ failure may not yield enough normal cells. In these situations, stem cells are envisioned as being an alternative source. Stem cells can be derived from discarded human embryos (human embryonic stem cells), from fetal tissue, or from adult sources (bone marrow, fat, skin). Therapeutic cloning offers a potentially limitless source of cells for tissue engineering applications. Summary: Recently, scientists in the fields of regenerative medicine and tissue engineering have applied the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues.",
keywords = "Bladder, Genital, Kidney, Reconstruction, Regenerative medicine",
author = "Anthony Atala",
year = "2006",
month = "7",
day = "1",
doi = "10.1097/01.mou.0000232055.20084.f6",
language = "English",
volume = "16",
pages = "305--309",
journal = "Current Opinion in Urology",
issn = "0963-0643",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Recent applications of regenerative medicine to urologic structures and related tissues

AU - Atala, Anthony

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Purpose of review: A severe shortage of donor tissues and organs exists, which is worsening yearly given the aging population. Currently, patients suffering from diseased and injured organs are treated with transplanted organs or cells. This paper reviews recent advances that have occurred in regenerative medicine and describes application of new technologies to treat diseased or damaged organs and tissues. Recent findings: Although most current strategies for tissue engineering depend upon a sample of autologous cells from the diseased organ of the patient, biopsies from patients with extensive end-stage organ failure may not yield enough normal cells. In these situations, stem cells are envisioned as being an alternative source. Stem cells can be derived from discarded human embryos (human embryonic stem cells), from fetal tissue, or from adult sources (bone marrow, fat, skin). Therapeutic cloning offers a potentially limitless source of cells for tissue engineering applications. Summary: Recently, scientists in the fields of regenerative medicine and tissue engineering have applied the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues.

AB - Purpose of review: A severe shortage of donor tissues and organs exists, which is worsening yearly given the aging population. Currently, patients suffering from diseased and injured organs are treated with transplanted organs or cells. This paper reviews recent advances that have occurred in regenerative medicine and describes application of new technologies to treat diseased or damaged organs and tissues. Recent findings: Although most current strategies for tissue engineering depend upon a sample of autologous cells from the diseased organ of the patient, biopsies from patients with extensive end-stage organ failure may not yield enough normal cells. In these situations, stem cells are envisioned as being an alternative source. Stem cells can be derived from discarded human embryos (human embryonic stem cells), from fetal tissue, or from adult sources (bone marrow, fat, skin). Therapeutic cloning offers a potentially limitless source of cells for tissue engineering applications. Summary: Recently, scientists in the fields of regenerative medicine and tissue engineering have applied the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues.

KW - Bladder

KW - Genital

KW - Kidney

KW - Reconstruction

KW - Regenerative medicine

UR - http://www.scopus.com/inward/record.url?scp=33745192067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745192067&partnerID=8YFLogxK

U2 - 10.1097/01.mou.0000232055.20084.f6

DO - 10.1097/01.mou.0000232055.20084.f6

M3 - Article

VL - 16

SP - 305

EP - 309

JO - Current Opinion in Urology

JF - Current Opinion in Urology

SN - 0963-0643

IS - 4

ER -